Cancer-Associated Molecular Signature in the Tissue Samples of Patients with Cirrhosis

Hepatology

Volumn 39, Issue 2, 2004, Pages 518-527

  Kim, Jin Woo ^a   Ye, Qinghai ^b   Forgues, Marshonna ^a   Chen, Yidong ^c   Budhu, Anuradha ^a   Sime, Jessica ^a   Hofseth, Lorne J ^a   Kaul, Rashmi ^d   Wang, Xin Wei ^a,e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b FUDAN UNIVERSITY   (China)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; COMPLEMENTARY DNA; MESSENGER RNA; SECRETORY PROTEIN; TUMOR ANTIGEN; TUMOR ASSOCIATED ANTIGEN GA733; TUMOR-ASSOCIATED ANTIGEN GA733;

ALCOHOL LIVER CIRRHOSIS; ARTICLE; AUTOIMMUNE HEPATITIS; BREAST CARCINOMA; CANCER CYTODIAGNOSIS; CANCER PATIENT; CANCER RISK; CANCER TISSUE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETIC CODE; GENETICS; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MOLECULAR BIOLOGY; MOLECULAR GENETICS; ONSET AGE; PRACTICE GUIDELINE; PRECANCER; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RISK FACTOR; SERUM; VALIDATION PROCESS; WILSON DISEASE;

ANTIGENS, NEOPLASM; CARCINOMA, HEPATOCELLULAR; CELL ADHESION MOLECULES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RISK FACTORS;

EID: 1242336973     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20053     Document Type: Article

References (36)

1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750.
2. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999;49:33-64.
3. Carr BI, Flickinger JC, Lotze MT. Hepatobiliary cancers: cancer of the liver. In: DeVita Jr VT, Hellman S, Rosenberg SA, eds. Cancer Principles and Practice of Oncology. Philadelphia: Lippincott-Raven, 1997:1087-1114.
4. Nakakura EK, Choti MA. Management of hepatocellular carcinoma. Oncology (Huntingt) 2000;14:1085-1098.
5. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
6. Kirimlioglu H, Dvorchick I, Ruppert K, Finkelstein S, Marsh JW, Iwatsuki S, Bonham A, et al. Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications. HEPATOLOGY 2001;34:502-510.
7. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002;31:339-346.
8. Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y, Tsunoda T, et al. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 2001;61:2129-2137.
9. Xu XR, Huang J, Xu ZG, Qian BZ, Zhu ZD, Yan Q, Cai T, et al. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci U S A 2001;98:15089-15094.
10. Shirota Y, Kaneko S, Honda M, Kawai HF, Kobayashi K. Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays. HEPATOLOGY 2001;33:832-840.
11. Smith MW, Yue ZN, Geiss GK, Sadovnikova NY, Carter VS, Boix L, Lazaro CA, et al. Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma. Cancer Res 2003;63:859-864.
12. Vauthey JN, Walsh GL, Vlastos G, Lauwers GY. Importance of field cancerisation in clinical oncology. Lancet Oncol 2000;1:15-16.
13. Raasch BA, Buettner PG. Multiple nonmelanoma skin cancer in an exposed Australian population. Int J Dermatol 2002;41:652-658.
14. Craig JR. Tumors of the liver. In: Zakim D, Boyer TD, eds. Hepatology: a Textbook of Liver Disease. Philadelphia: Saunders, 2003:1355-1370.
15. Tiribelli C, Melato M, Croce LS, Giarelli L, Okuda K, Ohnishi K. Prevalence of hepatocellular carcinoma and relation to cirrhosis: comparison of two different cities of the world-Trieste, Italy, and Chiba, Japan. HEPATOLOGY 1989;10:998-1002.
16. del Olmo JA, Serra MA, Rodriguez F, Escudero A, Gilabert S, Rodrigo JM. Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis. J Cancer Res Clin Oncol 1998;124:560-564.
17. El Serag HB. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 2002;35:S72-S78.
18. Wang XW, Hussain SP, Huo TI, Wu CG, Forgues M, Hofseth LJ, Brechot C, et al. Molecular pathogenesis of human hepatocellular carcinoma. Toxicology 2002;181/182:43-47.
19. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, Kumada H, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. HEPATOLOGY 1993;18:47-53.
20. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996;335:1570-1580.
21. Park SZ, Nagorney DM, Czaja AJ. Hepatocellular carcinoma in autoimmune hepatitis. Dig Dis Sci 2000;45:1944-1948.
22. Riordan SM, Williams R. The Wilson's disease gene and phenotypic diversity. J Hepatol 2001;34:165-171.
23. Ye QH, Qin LX, Forgues M, He P, Kim JW, Peng AC, Simon R, et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 2003;9:417-423.
24. Furey TS, Cristianini N, Duffy N, Bednarski DW, Schummer M, Haussler D. Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics 2000;16:906-914.
25. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95:14863-14868.
26. Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, Pacyna-Gengelbach M, Van De RM, et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A 2001;98:13784-13789.
27. Perou CM, Sorlie T, Eisen MB, Van De RM, Jeffrey SS, Rees CA, Pollack JR, et al. Molecular portraits of human breast tumours. Nature 2000;406:747-752.
28. Chen X, Cheung ST, So S, Fan ST, Barry C, Higgins J, Lai KM, et al. Gene expression patterns in human liver cancers. Mol Biol Cell 2002;13:1929-1939.
29. Koide N, Hada H, Shinji T, Ujike K, Hirasaki S, Yumoto Y, Hanafusa T, et al. Expression of the midkine gene in human hepatocellular carcinomas. Hepatogastroenterology 1999;46:3189-3196.
30. Ruck P, Wichert G, Handgretinger R, Kaiserling E. Ep-CAM in malignant liver tumours. J Pathol 2000;191:102-103.
31. Slaughter DP, Southwick HW, Smejkel W. 'Field cancerization' in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1953;6:963-968.
32. Hussain SP, Raja K, Amstad PA, Sawyer M, Trudel LJ, Wogan GN, Hofseth LJ, et al. Increased p53 mutation load in nontumorous human liver of Wilson disease and hemochromatosis: oxyradical overload diseases. Proc Natl Acad Sci U S A 2000;97:12770-12775.
33. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003;3:276-285.
34. Lip GY, Chin BS, Blann AD. Cancer and the prothrombotic state. Lancet Oncol 2002;3:27-34.
35. Balzar M, Winter MJ, de Boer CJ, Litvinov SV. The biology of the 17-1A antigen (Ep-CAM). J Mol Med 1999;77:699-712.
36. Litvinov SV, Balzar M, Winter MJ, Bakker HA, Briaire-de Bruijn IH, Prins F, Fleuren GJ, et al. Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins. J Cell Biol 1997;139:1337-1348.